Epithelial Ovarian Cancer - Platinum-resistant - Cytoreductive surgery - HIPEC - Quality of Life
Showing 1 - 25 of >10,000
Ovarian Cancer Trial in Goyang (Cisplatin)
Not yet recruiting
- Ovarian Cancer
-
Goyang, Gyeonggi, Korea, Republic ofNational Cancer Center
Apr 24, 2023
Cytoreductive Surgery Trial in Hangzhou (cytoreductive surgery)
Not yet recruiting
- Cytoreductive Surgery
- cytoreductive surgery
-
Hangzhou, China
- +1 more
Nov 30, 2022
Epithelial Ovarian Cancer Trial in Goyang-si (HIPEC)
Recruiting
- Epithelial Ovarian Cancer
- HIPEC
-
Goyang-si, Gyeonggi-do, Korea, Republic ofMyong Cheol Lim
Apr 23, 2022
Ovarian Cancer Trial in Houston (Cytoreductive surgery)
Recruiting
- Ovarian Cancer
- Cytoreductive surgery
-
Houston, TexasMD Anderson Cancer Center
Jul 28, 2022
Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)
Recruiting
- Stage III Ovarian Cancer
- +6 more
- Cytoreductive Surgery (CRS)
- +6 more
-
Baltimore, MarylandMercy Medical Center
Aug 30, 2022
Ovarian Cancer, Recurrent Ovarian Carcinoma Trial in Shibin Al Kawm (secondary cytoreductive surgery, Chemotherapy)
Withdrawn
- Ovarian Cancer
- Recurrent Ovarian Carcinoma
- secondary cytoreductive surgery
- Chemotherapy
-
Shibīn Al Kawm, Menoufia, EgyptMenoufia University, Faculty of medicine
Apr 9, 2022
Quality of Life After Low Anterior Resection During
Recruiting
- Ovarian Cancer
- +2 more
- Cytoreductive surgery
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 19, 2022
Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)
Not yet recruiting
- Stage III Ovarian Cancer
- +5 more
- Cisplatin
- No treatment
- (no location specified)
Dec 12, 2022
Ovarian Cancer, Intraperitoneal Chemo Trial in Montpellier (Intraperitoneal chemo during surgery)
Recruiting
- Ovarian Cancer
- Intraperitoneal Chemotherapy
- Intraperitoneal chemotherapy during surgery
-
Montpellier, FranceInstitut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial
Recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +32 more
- Carboplatin
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Ovarian Cancer Recurrent Trial in Uppsala (radical surgery with HIPEC)
Recruiting
- Ovarian Cancer Recurrent
- radical surgery with HIPEC
-
Uppsala, SwedenUppsala University Hopsital
Oct 1, 2021
Ovarian Cancer Trial in Naples (Olaparib, Chemotherapy drug)
Recruiting
- Ovarian Cancer
- Olaparib
- Chemotherapy drug
-
Naples, ItalyIRCCS Istituto Nazionale Tumori di Napoli
Feb 24, 2022
Ovarian Cancer, Fallopian Tubes Cancer, Peritoneal Cancer Trial in United States (Secondary Cytoreductive Surgery, Carboplatin
Active, not recruiting
- Ovarian Cancer
- +2 more
- Secondary Cytoreductive Surgery
- +2 more
-
Hartford, Connecticut
- +10 more
Feb 23, 2022
Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in
Not yet recruiting
- Ovarian Clear Cell Adenocarcinoma
- +14 more
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140
- +4 more
-
Buffalo, New York
- +1 more
Dec 16, 2022
Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive
Recruiting
- Malignant Abdominal Neoplasm
- +26 more
- Cisplatin
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Ovarian Cancer Trial (Cytoreductive Surgery (CRS), Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Neoadjuvant Chemotherapy
Completed
- Ovarian Cancer
- Cytoreductive Surgery (CRS)
- +4 more
- (no location specified)
Mar 17, 2021
Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8
Recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +26 more
- Biopsy
- +10 more
-
Duarte, California
- +2 more
Jan 25, 2023
Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States
Active, not recruiting
- Deleterious BARD1 Gene Mutation
- +13 more
- Laboratory Biomarker Analysis
- +4 more
-
Chicago, Illinois
- +8 more
Feb 25, 2022
Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)
Recruiting
- Bone Sarcoma
- +15 more
- Aldesleukin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Epithelial Ovarian Cancer, Acute Kidney Injury Due to Circulatory Failure Trial (Sodium Sulfate, Hydration, Cisplatin)
Not yet recruiting
- Epithelial Ovarian Cancer
- Acute Kidney Injury Due to Circulatory Failure
- Sodium Sulfate
- +2 more
- (no location specified)
May 17, 2023
Ovarian Cancer, Ovary Tumor, Ovarian Tumors Trial in Wuhan (HIPEC, CRS, IVCT)
Active, not recruiting
- Ovarian Cancer
- +5 more
- HIPEC
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
May 28, 2020
FIGO Stage III Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Carcinoma Trial in Amsterdam (Cisplatin 100 mg/m2, Cisplatin 40
Not yet recruiting
- FIGO Stage III Ovarian Cancer
- +2 more
- Cisplatin 100 mg/m2
- Cisplatin 40 mg/l
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek (NKI-AVL)
Jun 3, 2022
Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Linz (HIPEC, Carboplatin)
Withdrawn
- Epithelial Ovarian Cancer
- +2 more
- HIPEC
- Carboplatin
-
Linz, AustriaDepartment of gynaecology, Ordensklinikum Linz Ges.m.b.H, Barmhe
Mar 2, 2020
Ovarian Cancer, Hyperthermic Intraperitoneal Chemo Trial in Hangzhou (Hyperthermic Intraperitoneal Chemotherapy)
Recruiting
- Ovarian Cancer
- Hyperthermic Intraperitoneal Chemotherapy
- Hyperthermic Intraperitoneal Chemotherapy
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital, Zhejiang University, School Of M
May 15, 2020